We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Ins3.2
Insulin (bodybuilding use) Research
Mostly mechanism / observationalLimited safety
6 peer-reviewed studies
What the evidence says
Mostly mechanism / observational
Most Insulin (bodybuilding use) studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from mixed-quality meta-analyses and randomised trials published 1987–2019 with a typical study size of 173 participants.
Based on 6 studies · 1 meta-analysis · 1 RCT · 180 total participants
Confidence
Moderate
By outcome
Muscle protein & lean mass (claimed)
Mostly mechanism / observational4 studies
Glucose & hypoglycemia
Mostly mechanism / observational4 studies
Safety profile
Mostly mechanism / observational4 studies
Older research base
Newest study from 2019 · Latest meta-analysis: 2016
198720032019
1Meta-Analysisn=173 · medium study2016
Insulin did not affect MPS (WMD 3.90 [95% CI -0.74, 8.55], p = 0.71), but significantly reduced MPB (WMD -15.46 [95% CI -19.74, -11.18], p < 0.001).
Abdulla H, Smith K, Atherton PJ, Idris I. · Diabetologia (2016)
Systematic review and meta-analysis of insulin-infusion studies (44 studies reviewed, 25 meta-analyzed, 173 individuals) examining insulin's effect on muscle-protein synthesis (MPS) and breakdown (MPB)
Insulin did NOT significantly increase muscle-protein synthesis; it significantly REDUCED protein breakdown, improving net protein balance — i.e. its muscle action is anti-catabolic, not strongly anabolic
The synthesis effect was permissive and dependent on amino-acid availability — insulin alone, without extra amino acids, does not drive new muscle protein
In response to forearm hyperinsulinemia ... the net balance of phenylalanine and leucine became positive ... Despite the marked increase in net balance, the tissue Rd [synthesis] ... was unchanged.
Gelfand RA, Barrett EJ. · The Journal of clinical investigation (1987)
Classic human forearm-perfusion study in seven normal men measuring amino-acid kinetics across muscle before and during a physiologic insulin infusion
Insulin shifted muscle into net positive protein balance — but did so by suppressing protein breakdown (release), with little change in protein synthesis (disposal)
Foundational mechanistic evidence that insulin's anabolic action on human muscle is primarily ANTI-CATABOLIC
They have been strictly associated with serious adverse effects ... the short- as well as long-term consequences of such habits remain largely unrecognized.
Imperlini E, Mancini A, Alfieri A, Martone D, Caterino M, Orrù S, Buono P. · Molecular bioSystems (2015)
Review of the molecular harms of supraphysiologic performance-enhancing drug use, covering anabolic-androgenic steroids and peptide hormones (growth hormone and IGF-1) used for body shaping
Frames the broader metabolic and organ harm of supraphysiologic doping-agent misuse — the polypharmacy context in which insulin is typically used
Underscores that body-shaping drug misuse carries serious, often underrecognized adverse consequences, with no offsetting controlled performance benefit
A theoretical benefit of insulin abuse by body builders is that it is undetectable by currently available tests. A case is presented that highlights the dangers of such abuse.
Evans PJ, Lynch RM. · British journal of sports medicine (2003)
The field-defining report naming insulin as a drug of abuse in bodybuilding, presenting a case that highlights the dangers
Documents the key reason for misuse — insulin is undetectable by standard anti-doping tests — and the corresponding hazard
Establishes insulin abuse as a recognized, dangerous practice in strength sport rather than a fringe anecdote
We discuss the case of a 30-year-old male bodybuilder presenting with coma due to severe hypoglycemia ... subsequently found to be related to cryptic insulin injections.
Heidet M, Abdel Wahab A, Ebadi V, Cogne Y, Chollet-Xemard C, Khellaf M. · The Journal of emergency medicine (2019)
Case report of a 30-year-old male bodybuilder in coma from severe hypoglycemia, requiring iterative (repeated) glucose infusions, ultimately traced to surreptitious insulin injection
Warns emergency physicians that exogenous insulin injected as an ergogenic aid is a real cause of unexplained coma in strength athletes
The lethal-harm anchor: documents how non-medical insulin use lands a healthy young athlete in hypoglycemic coma needing intensive care
He injected 70 IE of a short-acting insulin subcutaneously, resulting in severe hypoglycaemia ... he lost consciousness and showed signs of convulsions.
Konrad C, Schüpfer G, Wietlisbach M, Gerber H. · Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie (1998)
Case report of a 30-year-old male bodybuilder who injected 70 IU of short-acting insulin to 'stimulate muscle growth' before a competition and developed severe hypoglycemia
He lost consciousness and convulsed; glucose remained low despite IV glucose and required glucagon plus intensive-care stabilization
An earlier, independent case confirming the same pattern — non-medical insulin in a bodybuilder causing life-threatening hypoglycemia